David Morland IV
David James Morland IV (born April 3, 1969) is a Canadian professional golfer who has played on the Canadian Tour, PGA Tour, and Nationwide Tour.Morland was born in North Bay, Ontario. He turned professional in 1991 after going to Kent State University. His first professional success came in the 1999 McDonald's Prince Edward Island Challenge on the Canadian Tour.
In late 1999 Morland finished tied for 16th place in the PGA Tour Q-school to gain a place on the tour for 2000. He had four seasons playing on the PGA Tour, 2000, 2001, 2002 and 2004, and competed in a total of 120 PGA Tour events. His best season was 2002 when he finished 150th in the money list. He had three top-10 finishes, his best being to be tied for 5th place in the 2001 Canadian Open.
Morland also played a number of seasons on the Nationwide Tour winning twice, the 2002 Hibernia Southern Open and the 2003 SAS Carolina Classic. He also lost a playoff for the New Zealand PGA Championship in 2007. 2003 was his best season, finishing 18th in the money list to regain his place on the PGA Tour.
Morland finished in third place in the 2020 European Senior Tour Q-school, gaining a place on the tour for 2020. In the 2020 Hoag Classic, a PGA Tour Champions event played in March, Morland led after a first round 61. He had further rounds of 70 and 71 to finish tied for 7th place. Provided by Wikipedia
Showing 1 - 12 results of 12 for search 'David Morland', query time: 0.04s
Refine Results
-
1
Healthy Organs Uptake on Baseline 18F-FDG PET/CT as an Alternative to Total Metabolic Tumor Volume to Predict Event-Free Survival in Classical Hodgkin's Lymphoma by David Morland, David Morland, David Morland, David Morland, Elizabeth Katherine Anna Triumbari, Elena Maiolo, Annarosa Cuccaro, Giorgio Treglia, Giorgio Treglia, Giorgio Treglia, Stefan Hohaus, Stefan Hohaus, Salvatore Annunziata
Published 2022-06-01
Article -
2
18F-FDG primary tumor uptake to improve N status prediction in cT1 non-metastatic non-small cell lung cancer: development and validation of a positron emission tomography model by David Morland, David Morland, David Morland, Marco Chiappetta, Marco Chiappetta, Pierre-Emmanuel Falcoz, Marie-Pierre Chenard, Salvatore Annunziata, Luca Boldrini, Filippo Lococo, Filippo Lococo, Alessio Imperiale, Alessio Imperiale, Alessio Imperiale
Published 2023-04-01
Article -
3
-
4
Radiomics in Oncological PET Imaging: A Systematic Review—Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers by David Morland, Elizabeth Katherine Anna Triumbari, Luca Boldrini, Roberto Gatta, Daniele Pizzuto, Salvatore Annunziata
Published 2022-05-01
Article -
5
-
6
-
7
Pretreatment CT Texture Parameters as Predictive Biomarkers of Progression-Free Survival in Follicular Lymphoma Treated with Immunochemotherapy and Rituximab Maintenance by Carole Durot, Eric Durot, Sébastien Mulé, David Morland, François Godard, Anne Quinquenel, Alain Delmer, Philippe Soyer, Christine Hoeffel
Published 2023-06-01
Article -
8
Baseline <sup>18</sup>F-FDG PET/CT Radiomics in Classical Hodgkin’s Lymphoma: The Predictive Role of the Largest and the Hottest Lesions by Elizabeth Katherine Anna Triumbari, Roberto Gatta, Elena Maiolo, Marco De Summa, Luca Boldrini, Marius E. Mayerhoefer, Stefan Hohaus, Lorenzo Nardo, David Morland, Salvatore Annunziata
Published 2023-04-01
Article -
9
Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and Rituximab by Cyrielle Rodier, Lukshe Kanagaratnam, David Morland, Adélie Herbin, Amandine Durand, Adrien Chauchet, Sylvain Choquet, Philippe Colin, René Olivier Casasnovas, Eric Deconinck, François Godard, Alain Delmer, Cédric Rossi, Eric Durot
Published 2023-05-01
Article -
10
<sup>18</sup>F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study by Daniele Antonio Pizzuto, Elizabeth Katherine Anna Triumbari, David Morland, Luca Boldrini, Roberto Gatta, Giorgio Treglia, Riccardo Bientinesi, Marco De Summa, Marina De Risi, Carmelo Caldarella, Eros Scarciglia, Angelo Totaro, Salvatore Annunziata
Published 2022-08-01
Article -
11
Baseline 18F-FDG Metabolic Tumor Volume Predicts Response to Rituximab Induction in Post-transplant Lymphoproliferative Disorders: A Multi-institutional Retrospective Study by David Morland, Lukshe Kanagaratnam, Fabrice Hubelé, Elise Toussaint, Sylvain Choquet, Aurélie Kas, Pierre-Ambroise Caquot, Corinne Haioun, Emmanuel Itti, Stéphane Leprêtre, Pierre Decazes, Fontanet Bijou, Paul Schwartz, Caroline Jacquet, Adrien Chauchet, Julien Matuszak, Nassim Kamar, Pierre Payoux, K-VIROGREF Study Group*, Eric Durot
Published 2023-02-01
Article -
12
One‐year COVID‐19 outcomes on the oncology care patient pathway: Results of a French descriptive, cross‐sectional comprehensive study (ONCOCARE‐COV) by Léonard Laurent, Mathias Brugel, Claire Carlier, Florentin Clere, Aurélie Bertrand, Damien Botsen, Camille Boulagnon‐Rombi, Véronique Dalstein, Adeline Debreuve‐Theresette, Sophie Deguelte, Christian Garbar, Rachid Mahmoudi, Antonin Marechal, David Morland, Jean‐Baptiste Rey, Claire Schvartz, Catherine Vallet, Yacine Merrouche, Florian Slimano, Olivier Bouché
Published 2022-12-01
Article